IBDEI1GO ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23631,1,4,0)
;;=4^D68.8
;;^UTILITY(U,$J,358.3,23631,2)
;;=^5002363
;;^UTILITY(U,$J,358.3,23632,0)
;;=D68.318^^79^1021^13
;;^UTILITY(U,$J,358.3,23632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23632,1,3,0)
;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antib/Inhib
;;^UTILITY(U,$J,358.3,23632,1,4,0)
;;=4^D68.318
;;^UTILITY(U,$J,358.3,23632,2)
;;=^340504
;;^UTILITY(U,$J,358.3,23633,0)
;;=D68.32^^79^1021^12
;;^UTILITY(U,$J,358.3,23633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23633,1,3,0)
;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
;;^UTILITY(U,$J,358.3,23633,1,4,0)
;;=4^D68.32
;;^UTILITY(U,$J,358.3,23633,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,23634,0)
;;=I10.^^79^1021^14
;;^UTILITY(U,$J,358.3,23634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23634,1,3,0)
;;=3^Hypertension,Essential
;;^UTILITY(U,$J,358.3,23634,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,23634,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,23635,0)
;;=I82.401^^79^1021^3
;;^UTILITY(U,$J,358.3,23635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23635,1,3,0)
;;=3^Acute Embolism/Thrombos Deep Veins,Rt Lower Extrem,Unspec
;;^UTILITY(U,$J,358.3,23635,1,4,0)
;;=4^I82.401
;;^UTILITY(U,$J,358.3,23635,2)
;;=^5007854
;;^UTILITY(U,$J,358.3,23636,0)
;;=I82.402^^79^1021^2
;;^UTILITY(U,$J,358.3,23636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23636,1,3,0)
;;=3^Acute Embolism/Thrombos Deep Veins,Lt Lower Extrem,Unspec
;;^UTILITY(U,$J,358.3,23636,1,4,0)
;;=4^I82.402
;;^UTILITY(U,$J,358.3,23636,2)
;;=^5007855
;;^UTILITY(U,$J,358.3,23637,0)
;;=I82.890^^79^1021^1
;;^UTILITY(U,$J,358.3,23637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23637,1,3,0)
;;=3^Acute Embolism/Thromb of Other Specified Veins
;;^UTILITY(U,$J,358.3,23637,1,4,0)
;;=4^I82.890
;;^UTILITY(U,$J,358.3,23637,2)
;;=^5007938
;;^UTILITY(U,$J,358.3,23638,0)
;;=I82.891^^79^1021^10
;;^UTILITY(U,$J,358.3,23638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23638,1,3,0)
;;=3^Chronic Embolism/Thrombo of Other Specified Veins
;;^UTILITY(U,$J,358.3,23638,1,4,0)
;;=4^I82.891
;;^UTILITY(U,$J,358.3,23638,2)
;;=^5007939
;;^UTILITY(U,$J,358.3,23639,0)
;;=D68.62^^79^1021^16
;;^UTILITY(U,$J,358.3,23639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23639,1,3,0)
;;=3^Lupus Anticoagulant Syndrome
;;^UTILITY(U,$J,358.3,23639,1,4,0)
;;=4^D68.62
;;^UTILITY(U,$J,358.3,23639,2)
;;=^5002361
;;^UTILITY(U,$J,358.3,23640,0)
;;=I48.20^^79^1021^4
;;^UTILITY(U,$J,358.3,23640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23640,1,3,0)
;;=3^Atrial Fibrillation,Chronic,Unspec
;;^UTILITY(U,$J,358.3,23640,1,4,0)
;;=4^I48.20
;;^UTILITY(U,$J,358.3,23640,2)
;;=^5158048
;;^UTILITY(U,$J,358.3,23641,0)
;;=I48.21^^79^1021^8
;;^UTILITY(U,$J,358.3,23641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23641,1,3,0)
;;=3^Atrial Fibrillation,Permanent
;;^UTILITY(U,$J,358.3,23641,1,4,0)
;;=4^I48.21
;;^UTILITY(U,$J,358.3,23641,2)
;;=^304710
;;^UTILITY(U,$J,358.3,23642,0)
;;=I48.11^^79^1021^5
;;^UTILITY(U,$J,358.3,23642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23642,1,3,0)
;;=3^Atrial Fibrillation,Longstanding Persistent
;;^UTILITY(U,$J,358.3,23642,1,4,0)
;;=4^I48.11
;;^UTILITY(U,$J,358.3,23642,2)
;;=^5158046
;;^UTILITY(U,$J,358.3,23643,0)
;;=I48.19^^79^1021^6
;;^UTILITY(U,$J,358.3,23643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23643,1,3,0)
;;=3^Atrial Fibrillation,Other Persistent
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1GO 3819 printed Apr 09, 2024@21:39:13 Page 2
IBDEI1GO ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23631,1,4,0)
+2 ;;=4^D68.8
+3 ;;^UTILITY(U,$J,358.3,23631,2)
+4 ;;=^5002363
+5 ;;^UTILITY(U,$J,358.3,23632,0)
+6 ;;=D68.318^^79^1021^13
+7 ;;^UTILITY(U,$J,358.3,23632,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,23632,1,3,0)
+10 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antib/Inhib
+11 ;;^UTILITY(U,$J,358.3,23632,1,4,0)
+12 ;;=4^D68.318
+13 ;;^UTILITY(U,$J,358.3,23632,2)
+14 ;;=^340504
+15 ;;^UTILITY(U,$J,358.3,23633,0)
+16 ;;=D68.32^^79^1021^12
+17 ;;^UTILITY(U,$J,358.3,23633,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,23633,1,3,0)
+20 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
+21 ;;^UTILITY(U,$J,358.3,23633,1,4,0)
+22 ;;=4^D68.32
+23 ;;^UTILITY(U,$J,358.3,23633,2)
+24 ;;=^5002357
+25 ;;^UTILITY(U,$J,358.3,23634,0)
+26 ;;=I10.^^79^1021^14
+27 ;;^UTILITY(U,$J,358.3,23634,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,23634,1,3,0)
+30 ;;=3^Hypertension,Essential
+31 ;;^UTILITY(U,$J,358.3,23634,1,4,0)
+32 ;;=4^I10.
+33 ;;^UTILITY(U,$J,358.3,23634,2)
+34 ;;=^5007062
+35 ;;^UTILITY(U,$J,358.3,23635,0)
+36 ;;=I82.401^^79^1021^3
+37 ;;^UTILITY(U,$J,358.3,23635,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,23635,1,3,0)
+40 ;;=3^Acute Embolism/Thrombos Deep Veins,Rt Lower Extrem,Unspec
+41 ;;^UTILITY(U,$J,358.3,23635,1,4,0)
+42 ;;=4^I82.401
+43 ;;^UTILITY(U,$J,358.3,23635,2)
+44 ;;=^5007854
+45 ;;^UTILITY(U,$J,358.3,23636,0)
+46 ;;=I82.402^^79^1021^2
+47 ;;^UTILITY(U,$J,358.3,23636,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,23636,1,3,0)
+50 ;;=3^Acute Embolism/Thrombos Deep Veins,Lt Lower Extrem,Unspec
+51 ;;^UTILITY(U,$J,358.3,23636,1,4,0)
+52 ;;=4^I82.402
+53 ;;^UTILITY(U,$J,358.3,23636,2)
+54 ;;=^5007855
+55 ;;^UTILITY(U,$J,358.3,23637,0)
+56 ;;=I82.890^^79^1021^1
+57 ;;^UTILITY(U,$J,358.3,23637,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,23637,1,3,0)
+60 ;;=3^Acute Embolism/Thromb of Other Specified Veins
+61 ;;^UTILITY(U,$J,358.3,23637,1,4,0)
+62 ;;=4^I82.890
+63 ;;^UTILITY(U,$J,358.3,23637,2)
+64 ;;=^5007938
+65 ;;^UTILITY(U,$J,358.3,23638,0)
+66 ;;=I82.891^^79^1021^10
+67 ;;^UTILITY(U,$J,358.3,23638,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,23638,1,3,0)
+70 ;;=3^Chronic Embolism/Thrombo of Other Specified Veins
+71 ;;^UTILITY(U,$J,358.3,23638,1,4,0)
+72 ;;=4^I82.891
+73 ;;^UTILITY(U,$J,358.3,23638,2)
+74 ;;=^5007939
+75 ;;^UTILITY(U,$J,358.3,23639,0)
+76 ;;=D68.62^^79^1021^16
+77 ;;^UTILITY(U,$J,358.3,23639,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,23639,1,3,0)
+80 ;;=3^Lupus Anticoagulant Syndrome
+81 ;;^UTILITY(U,$J,358.3,23639,1,4,0)
+82 ;;=4^D68.62
+83 ;;^UTILITY(U,$J,358.3,23639,2)
+84 ;;=^5002361
+85 ;;^UTILITY(U,$J,358.3,23640,0)
+86 ;;=I48.20^^79^1021^4
+87 ;;^UTILITY(U,$J,358.3,23640,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,23640,1,3,0)
+90 ;;=3^Atrial Fibrillation,Chronic,Unspec
+91 ;;^UTILITY(U,$J,358.3,23640,1,4,0)
+92 ;;=4^I48.20
+93 ;;^UTILITY(U,$J,358.3,23640,2)
+94 ;;=^5158048
+95 ;;^UTILITY(U,$J,358.3,23641,0)
+96 ;;=I48.21^^79^1021^8
+97 ;;^UTILITY(U,$J,358.3,23641,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,23641,1,3,0)
+100 ;;=3^Atrial Fibrillation,Permanent
+101 ;;^UTILITY(U,$J,358.3,23641,1,4,0)
+102 ;;=4^I48.21
+103 ;;^UTILITY(U,$J,358.3,23641,2)
+104 ;;=^304710
+105 ;;^UTILITY(U,$J,358.3,23642,0)
+106 ;;=I48.11^^79^1021^5
+107 ;;^UTILITY(U,$J,358.3,23642,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,23642,1,3,0)
+110 ;;=3^Atrial Fibrillation,Longstanding Persistent
+111 ;;^UTILITY(U,$J,358.3,23642,1,4,0)
+112 ;;=4^I48.11
+113 ;;^UTILITY(U,$J,358.3,23642,2)
+114 ;;=^5158046
+115 ;;^UTILITY(U,$J,358.3,23643,0)
+116 ;;=I48.19^^79^1021^6
+117 ;;^UTILITY(U,$J,358.3,23643,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,23643,1,3,0)
+120 ;;=3^Atrial Fibrillation,Other Persistent
